Tel Aviv Stock Exchange Sees Divergence as TA-90 Index Drops 20% in Five Months
Translated & summarized from Bizportal by baba
The Tel Aviv Stock Exchange's TA-90 index has fallen 20% in five months, significantly underperforming the TA-35 index's 16% rise over 12 months. This divergence is due to the composition of the indices, with large-cap stocks driving the TA-35's gains. Next Vision, a component of the TA-90, has seen its stock price drop 50% from its peak amid aggressive selling by Fidelity and concerns about competition.
The story in 6 lines · by baba
- The TA-90 index has dropped 20% from its peak in the last five months.
- The TA-35 index has risen 16% over the past 12 months.
- Next Vision stock has fallen 50% from its peak, losing 11.4% on the report day.
- Fidelity's aggressive selling is cited as a reason for Next Vision's sharp decline.
- Concerns about competition are impacting Next Vision's future growth prospects.
- Israeli institutional investors are reportedly buying into Next Vision's stock despite the downturn.
The Tel Aviv Stock Exchange (TASE) is experiencing significant divergence between its major indices, with the TA-90 index, representing the 90 largest stocks after the top 35, falling 20% from its peak five months ago. This contrasts sharply with the TA-35 index of the largest companies, which has risen approximately 16% over the past 12 months, and the TA-125 index, which has seen a 10% increase in the same period. The underperformance of the TA-90 is attributed to its composition, with the TA-35 boosted by strong returns from companies like Teva and Palo Alto. Without these key performers, the TA-35's gains would have been less than 5%.
One notable stock contributing to the TA-90's decline is Next Vision, which has plummeted 50% from its peak, including an 11.4% drop on the day of the report, following a previous 12% loss. This sharp decline is reportedly driven by aggressive selling by Fidelity. Despite the company's attempts to mitigate the impact, including announcing a contract win, the stock continued to fall, suggesting management is under pressure. The company's valuation, with a price-to-earnings ratio of 41, is now being scrutinized, especially given concerns about increased competition impacting its core business.
While institutional investors in Israel are reportedly buying into the dip, suggesting they believe there is no immediate threat, the market sentiment remains cautious. The article questions whether these investors possess information about the business or competitive landscape that the broader market lacks, or if they are simply receiving assurances from the company's management.
